ABL
Celine Schneider has a strong background in laboratory work, with extensive experience in microbiology and quality control. CELINE has worked in various companies where CELINE has conducted water and air sampling, fertility and sterility tests, as well as microbiological analyzes in pharmaceutical and food industries. Celine has also been involved in managing laboratory services, writing procedures, managing stocks, and maintenance of equipment. Additionally, CELINE has experience in plastics manufacturing, specifically working on an injection press performing quality control, assembly, and packaging tasks. With a focus on quality assurance and meticulous attention to detail, Celine has demonstrated their expertise in various roles within the laboratory and manufacturing industries.
ABL
From development to market ABL Europe provides GMP viral vectors, contributing to the success of our clients’ immunotherapy innovations. ABL Europe SAS is a pure-play GMP CMO licensed in accordance with EMA, completely dedicated to the provision of viral vector GMP contract manufacturing services, and a subsidiary of ABL Inc. under the corporate ownership of Institut Mérieux. ABL has a strong technical & regulatory track record in process development, scale-up & GMP manufacturing of filterable & non-sterile filterable (aseptic processing) viral vectors used in all phases of clinical development globally. With different adherent platforms (< 60 m2) and suspension (< 500 L) capabilities for drug substance and drug product (< 10,000 vials per batch) in-house, experience in process characterisation and validation, ABL provides its clients with a long-term strategic manufacturing option through clinical development & licensure for a range of virus vector gene therapy & vaccine products. ABL Europe’s clients are located worldwide.